These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26256868)

  • 21. Mammalian target of rapamycin signaling in the podocyte.
    Inoki K; Huber TB
    Curr Opin Nephrol Hypertens; 2012 May; 21(3):251-7. PubMed ID: 22388550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steady-state kinetic and inhibition studies of the mammalian target of rapamycin (mTOR) kinase domain and mTOR complexes.
    Tao Z; Barker J; Shi SD; Gehring M; Sun S
    Biochemistry; 2010 Oct; 49(39):8488-98. PubMed ID: 20804212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mTOR Signalling in Health and Disease.
    Proud CG
    Biochem Soc Trans; 2011 Apr; 39(2):431-6. PubMed ID: 21428914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PI3K/mTOR signaling pathways in medulloblastoma.
    Mohan AL; Friedman MD; Ormond DR; Tobias M; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2012 Aug; 32(8):3141-6. PubMed ID: 22843885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of mTOR-mediated signals during haemopoiesis and lineage commitment.
    Malik N; Sansom OJ; Michie AM
    Biochem Soc Trans; 2018 Oct; 46(5):1313-1324. PubMed ID: 30154096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.
    McCubrey JA; Steelman LS; Bertrand FE; Davis NM; Abrams SL; Montalto G; D'Assoro AB; Libra M; Nicoletti F; Maestro R; Basecke J; Cocco L; Cervello M; Martelli AM
    Leukemia; 2014 Jan; 28(1):15-33. PubMed ID: 23778311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Talks about TORCs: recent advancesin target of rapamycin signalling. On mTOR nomenclature.
    Hall MN
    Biochem Soc Trans; 2013 Aug; 41(4):887-8. PubMed ID: 23863150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deconstructing mTOR complexes in regulation of Glioblastoma Multiforme and its stem cells.
    Jhanwar-Uniyal M; Jeevan D; Neil J; Shannon C; Albert L; Murali R
    Adv Biol Regul; 2013 May; 53(2):202-10. PubMed ID: 23231881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle regulation by the nutrient-sensing mammalian target of rapamycin (mTOR) pathway.
    Cuyàs E; Corominas-Faja B; Joven J; Menendez JA
    Methods Mol Biol; 2014; 1170():113-44. PubMed ID: 24906312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.
    Dorritie KA; McCubrey JA; Johnson DE
    Leukemia; 2014 Feb; 28(2):248-57. PubMed ID: 23797472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond control of protein translation: what we have learned about the non-canonical regulation and function of mammalian target of rapamycin (mTOR).
    Malik AR; Urbanska M; Macias M; Skalecka A; Jaworski J
    Biochim Biophys Acta; 2013 Jul; 1834(7):1434-48. PubMed ID: 23277194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RAD 001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia.
    Mancini M; Petta S; Martinelli G; Barbieri E; Santucci MA
    J Cell Biochem; 2010 Feb; 109(2):320-8. PubMed ID: 20014066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTOR as a central hub of nutrient signalling and cell growth.
    Kim J; Guan KL
    Nat Cell Biol; 2019 Jan; 21(1):63-71. PubMed ID: 30602761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TOR signaling regulates planarian stem cells and controls localized and organismal growth.
    Peiris TH; Weckerle F; Ozamoto E; Ramirez D; Davidian D; García-Ojeda ME; Oviedo NJ
    J Cell Sci; 2012 Apr; 125(Pt 7):1657-65. PubMed ID: 22427692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mTORC1- and mTORC2-interacting proteins keep their multifunctional partners focused.
    Bracho-Valdés I; Moreno-Alvarez P; Valencia-Martínez I; Robles-Molina E; Chávez-Vargas L; Vázquez-Prado J
    IUBMB Life; 2011 Oct; 63(10):896-914. PubMed ID: 21905202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Requirement for lysosomal localization of mTOR for its activation differs between leucine and other amino acids.
    Averous J; Lambert-Langlais S; Carraro V; Gourbeyre O; Parry L; B'Chir W; Muranishi Y; Jousse C; Bruhat A; Maurin AC; Proud CG; Fafournoux P
    Cell Signal; 2014 Sep; 26(9):1918-27. PubMed ID: 24793303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.
    Zha X; Hu Z; Ji S; Jin F; Jiang K; Li C; Zhao P; Tu Z; Chen X; Di L; Zhou H; Zhang H
    Cancer Lett; 2015 Apr; 359(1):97-106. PubMed ID: 25578782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulating mTOR in aging and health.
    Johnson SC; Sangesland M; Kaeberlein M; Rabinovitch PS
    Interdiscip Top Gerontol; 2015; 40():107-27. PubMed ID: 25341517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.